Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and ROS signalingChunmei Xiu, Jianquan Chen, Kaizhong Ji et al.|Metabolism|2025Cited by 15
Temporal Trends in the Burden of Diabetes and Its Risk Factors Across the Western Pacific Region Between 1990 and 2044: A Systematic Analysis of the Global Burden of Disease Study 2019Xinwei Liu, Ye Li, Bing Wu et al.|Diabetes/Metabolism Research and Reviews|2025Cited by 6
Additional file 1 of Factors that dynamically affect provincial incidences of catastrophic health expenditure among middle-aged and elderly Chinese population-transition of disease financial risk protection from global to localXiyu Zhang, Qunhong Wu, Wenqing Miao et al.|Figshare|2022Cited by 0